Professional Advisory Services Inc Gilead Sciences, Inc. Transaction History

Professional Advisory Services Inc

  • $762 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 30, 2019
SELL
$61.87 - $69.38 $422,262 - $473,518
-6,825 Closed
0 $0
Q4 2018

Jan 17, 2019
SELL
$60.54 - $79.0 $71,134 - $92,825
-1,175 Reduced 14.69%
6,825 $427,000
Q4 2017

Jan 19, 2018
BUY
$71.15 - $83.52 $569,200 - $668,160
8,000
8,000 $573,000

Others Institutions Holding GILD

# of Institutions
1,926
Shares Held
993M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Professional Advisory Services Inc Portfolio

Follow Professional Advisory Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Professional Advisory Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Professional Advisory Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email